C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
10/2011
10/13/2011	US20110251208 Phosphodiesterase type iii (pde iii) inhibitors or ca2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
10/13/2011	US20110251200 Aryl guanidine f1f0-atpase inhibitors and related methods
10/13/2011	US20110251197 Lysosomotropic inhibitors of acid ceramidase
10/13/2011	US20110251187 Heterocyclic compound
10/13/2011	US20110251165 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
10/12/2011	EP2374807A2 An improved process for the isolation of temozolomide
10/12/2011	EP2374799A1 Process for the preparation of 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylates
10/12/2011	EP2373670A2 Novel amino substituted c-glycoside derivatives and use thereof as cosmetic
10/12/2011	EP2373627A1 1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as cb2 receptor agonists
10/12/2011	EP2138480B1 Method for production of n-(2-amino-1,2-dicyanovinyl)imidates and method for production of aminoimidazole derivatives
10/12/2011	EP1385820B1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
10/12/2011	CN102216278A Novel crosslinked hexaaryl bisimidazole compound and derivative thereof, method for producing the compound and precursor compound to be used in the production method
10/12/2011	CN102210663A Diarylalkanes as potent inhibitors of binuclear enzymes
10/12/2011	CN101417978B Method for preparing 1,3-dibenzyl-5-formyl-4-alkoxycarbonyl-imidazoline-2-one
10/11/2011	US8034956 Ionic liquid and method for producing the same, method for forming oxide film on metal surface, electrolyte capacitor and electrolyte
10/11/2011	US8034811 Hydroxamic acid esters and pharmaceutical use thereof
10/11/2011	US8034810 Matrix metalloproteinase inhibitors; antiinflammatory agengs; rheumatoid arthritis, osteoarthritis; antitumor, anticarcinogenic, and antimetastasis agents; respiratory system disorders, chronic obstructive pulmonary disease, deblocking, deprotecting
10/11/2011	CA2551909C Substituted azole derivatives, compositions, and methods of use
10/11/2011	CA2511969C Process for preparing substituted imidazole derivatives and intermediates used in the process
10/11/2011	CA2457054C Activator of peroxisome proliferator-activated receptor .delta.
10/06/2011	WO2011122509A1 Ester compound and use thereof
10/06/2011	WO2011071767A3 Aminomethyl-substituted imidazole compounds for use as friction modifiers in lubricating oil compositions
10/06/2011	US20110245311 Histidine Derivatives
10/06/2011	US20110244058 Compositions and methods for treatment of pulmonary diseases and conditions
10/06/2011	US20110243865 Melanin production inhibitor
10/05/2011	EP2371821A1 Volatile imidazoles and group 2 imidazole based metal precursors
10/05/2011	EP2371421A1 Ligands of insulin degrading enzyme and their uses
10/05/2011	EP2371366A1 Heterocyclo inhibitors of potassium channel function
10/05/2011	EP1968963B1 Substituted propiolic acid amides and their use for producing analgesics
10/05/2011	CN201999875U 2-methylimidazole continuous synthesis and separation device
10/05/2011	CN1845933B Specific glucocorticosteriod compound having anti-inflamatory activity
10/05/2011	CN102206238A Method for rapidly preparing oligosaccharide by using ionic liquid load and immediate compound thereof
10/05/2011	CN102206226A N-heterocyclic carbine metal complex connected with trimethyl benzene, and preparation method thereof
10/05/2011	CN102206185A Process for refining bendazac lysine and analogs thereof
10/05/2011	CN101535272B Method for preparing medetomidine and its salts
10/04/2011	US8030494 Optical recording material
10/04/2011	US8030339 Imidazole derivatives for the treatment of anxiety and related diseases
10/04/2011	US8030338 Method for producing 2-nitroimidazole derivative
09/2011
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011080132A3 Compounds, compositions and methods for controlling biofilms
09/29/2011	US20110237639 Imidazolinylmethyl aryl sulfonamide
09/29/2011	US20110237633 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/29/2011	US20110237595 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
09/29/2011	US20110237528 Compositions and methods comprising imidazole and triazole derivatives
09/29/2011	US20110233048 Photobase generator
09/28/2011	EP2368875A1 Photobase generator
09/28/2011	EP2368550A1 Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
09/28/2011	EP2231586B1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors
09/28/2011	EP1912972B1 Substituted imidazole compounds as ksp inhibitors
09/28/2011	EP1660457B1 Ionic liquids based on imidazolium salts incorporating a nitrile functionality
09/28/2011	EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta
09/28/2011	CN102203056A Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof
09/28/2011	CN102203055A Nitric oxide releasing amino acid ester compound, composition and method of use
09/28/2011	CN102203050A Method for making carbamates, ureas and isocyanates
09/28/2011	CN102199147A Nitroimidazole derivative in therapy
09/28/2011	CN102199126A Preparation method of dialkyl imidazoles
09/28/2011	CN102199125A Fluorine-containing imidazoline derivatives and preparation method thereof
09/28/2011	CN102199124A Lewis acid-catalyzed cascade reaction-based method for synthesizing imidazolidine with multiple functional groups
09/28/2011	CN102199096A Method for synthesizing organic ionic compounds
09/27/2011	US8026374 Process for preparing (meth)acrylic esters of N-hydroxyalkylated imidazoles
09/27/2011	US8026362 Non-nucleoside reverse transcriptase inhibitors
09/27/2011	US8026265 Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors
09/27/2011	US8026239 Cell differentiation inducer
09/27/2011	CA2457410C Compounds effecting glucokinase
09/27/2011	CA2440630C Metalloproteinase inhibitors
09/27/2011	CA2440042C Carboxamide derivatives as therapeutic agents
09/22/2011	WO2011115065A1 Cyclopropanecarboxylic acid derivative
09/22/2011	WO2011115064A1 Cycloalkyl-substituted imidazole derivative
09/22/2011	WO2011025982A3 Tetracycline compounds
09/22/2011	US20110230550 Compounds, compositions and methods
09/22/2011	US20110230535 Imidazolinylmethyl aryl sulfonamide
09/22/2011	US20110230533 Imidazolidinedione derivatives as antimalarial agents, preparation thereof, and methods of use
09/22/2011	US20110230479 Neurotrophin mimetics and uses thereof
09/22/2011	US20110230452 Compounds and methods for the treatment of pain and other diseases
09/22/2011	US20110230446 Cathepsin cysteine protease inhibitors
09/22/2011	US20110230442 Na channels, disease, and related assays and compositions
09/22/2011	US20110230428 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
09/22/2011	DE102010012235A1 New substituted imidazole compounds, useful e.g. to treat cancer, pathological consequences of alcohol abuse, viral hepatitis, acute and chronic pancreatitis, toxic renal disease and hepatic insulin resistance in diabetes mellitus
09/22/2011	DE102010012233A1 New substituted imidazole compounds, useful e.g. to treat cancer, pathological consequences of alcohol abuse, viral hepatitis, acute and chronic pancreatitis, toxic renal disease and hepatic insulin resistance in diabetes mellitus
09/22/2011	DE102010012232A1 New imidazole useful in pharmaceutical preparation e.g. for prevention or treatment of cancer diseases, pathological effects of alcohol misuse, viral hepatitis, steatohepatitis, acute and chronic pancreatitis, toxic renal diseases
09/22/2011	CA2793523A1 Cyclopropanecarboxylic acid derivative
09/22/2011	CA2791505A1 Cycloalkyl-substituted imidazole derivative
09/21/2011	EP2366693A1 Nitroimidazole-amino acid compound type nuclide hypoxia imaging agent and intermediates for preparing them
09/21/2011	EP2366692A2 Copper electropating bath and method
09/21/2011	EP2366686A2 Copper electroplating bath and method
09/21/2011	EP2238116B1 Novel imidazolinylmethyl aryl sulfonamides
09/21/2011	EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
09/21/2011	CN102196819A Composition for local anesthesia
09/21/2011	CN102190683A Phosphorous anion ionic liquid and preparation method thereof
09/21/2011	CN102190626A Synthesis method of sodium glycididazole
09/21/2011	CN102190625A Stilbene tumor targeted medicine Combretastatin A4 analogs
09/21/2011	CN102190624A Sulfur-containing/nitrogen-group-containing ionic liquid and preparation method thereof
09/21/2011	CN102190623A Method for preparing imidazole acetate ionic liquid
09/20/2011	US8022226 Nonsedating α-2 agonists
09/20/2011	US8022092 (2,5-dioxoimidazolidin-1-yl)-N-hydroxy-acetamides as metalloproteinase inhibitors
09/20/2011	US8022079 Methods of modulating PPAR gamma-type receptors
09/20/2011	US8022074 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
09/20/2011	US8022072 Azolylmethylidenehydrazine derivative and use thereof
09/20/2011	CA2589146C Process for producing muscarine receptor antagonist and intermediate therefor
09/20/2011	CA2505033C Non-nucleoside reverse transcriptase inhibitors

1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 345